Clinical Trials Directory

Trials / Unknown

UnknownNCT04313959

Comparison Erect Spine in Cardiac Surgery

Comparison of Two Anesthetic Techniques in Blocking the Erector Plane of the Spine Bilateral in Cardiac Surgery: a Prospective Randomized Double-blinded Clinical Trial

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Instituto do Coracao · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Open cardiac surgeries are characterized by the increased use of opioids and longer extubation times, being post-sternotomy pain one of the causes of greater patient discomfort, plexus blockages have been used more frequently given the good results of anatomical studies and case series that are just beginning to be published. however, there is not enough data to convince the scientific community of its advantages, continuing to carry out its performance due to lack of evidence. Dexamethasone also shows an excellent result blocking the inflammatory chain and it was evidenced that it prolongs the time of blockages when used perineurally in the plexus blockages. This study wants to show the improvement of pain in patients who undergo this type of surgery and also show the advantages of a longer blockage, which can reduce use of analgesic and opioids, as well as decrease the time of hospitalization This is a double-blinded, randomized, clinical trial designed to determine the efficacy of spine erector whit dexamethasone gives more duration of the blockage and less pain after cardiac surgery.

Detailed description

Evaluation of acute pain pos cardiac surgery in patients that who were subjected at myocardial revascularization. We offer Espine erector block (ESP) with linear array Transducer and needle 100mm bilateral as a technique that offer results more hopeful and less invasive in patients with open cardiac surgery. Favoring the implementation of Fastrack anesthesia techniques in cardiac surgery and minimizing complications in this group of patients

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine 0.2% Injectable SolutionSingle-shot ultrasound-guided erector spine plane block of 0.2% ropivacaine
DRUGRopivacaine 0.2% + DexamethasoneAddiction of 5 mg/ml dexamethasone in 0.2% ropivacaine solution

Timeline

Start date
2022-01-20
Primary completion
2023-02-25
Completion
2023-04-17
First posted
2020-03-18
Last updated
2022-07-18

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04313959. Inclusion in this directory is not an endorsement.